Application | Comment | Organism |
---|---|---|
medicine | infection of HL-60 cells with Anaplasma phagocytophilum results in elevated cathepsin L activity and the proteolysis of CDP. Blocking the action of cathepsin L with a chemical inhibitor or siRNA causes a marked reduction in the degree of Anaplasma phagocytophilum infection. Increasing cathepsin L activity is a strategy used by Anaplasma phagocytophilum to alter CDP activity and thereby globallly influence neutrophil function | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
infected with Anaplasma phagocytophilum | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
HL-60 cell | infection with Anaplasma phagocytophilum results in elevated cathepsin L activity and the proteolysis of CDP | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
(benzyloxycarbonyl-Phe-Arg)2-R110 + H2O | rhodamine-labeled substrate | Homo sapiens | ? | - |
? |